HUP0302060A2 - Eljárás készítmények elżállítására - Google Patents
Eljárás készítmények elżállításáraInfo
- Publication number
- HUP0302060A2 HUP0302060A2 HU0302060A HUP0302060A HUP0302060A2 HU P0302060 A2 HUP0302060 A2 HU P0302060A2 HU 0302060 A HU0302060 A HU 0302060A HU P0302060 A HUP0302060 A HU P0302060A HU P0302060 A2 HUP0302060 A2 HU P0302060A2
- Authority
- HU
- Hungary
- Prior art keywords
- expanded
- solution
- relates
- homogeneous dispersion
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 239000007970 homogeneous dispersion Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000009835 boiling Methods 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000006260 foam Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oncology (AREA)
- Child & Adolescent Psychology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A találmány expandált, mechanikailag stabil, lamelláris, porózus,szivacsszerű vagy habszerkezet alakjában levő kompozíciók, előnyösengyógyászati készítmények oldatokból és diszperziókból történőelőállítására vonatkozik. Az eljárás az alábbi lépésekből áll: a)valamely folyadékból és egy vagy több gyógyászati hatóanyagból, egyvagy több gyógyászatilag alkalmas excípiensből vagy ezek keverékébőloldatot vagy homogén diszperziót készítenek; majd b) az oldatot vagyhomogén diszperziót forralás nélkül expandálják. A találmány továbbá afenti eljárással előállított kompozíciókra, ezek feldolgozására és amegfelelő adagolási formákra vonatkozik. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00113535 | 2000-06-27 | ||
PCT/EP2001/006834 WO2002000201A2 (en) | 2000-06-27 | 2001-06-18 | Method for preparing a composition |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0302060A2 true HUP0302060A2 (hu) | 2003-09-29 |
HUP0302060A3 HUP0302060A3 (en) | 2006-07-28 |
HU229550B1 HU229550B1 (en) | 2014-01-28 |
Family
ID=8169074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0302060A HU229550B1 (en) | 2000-06-27 | 2001-06-18 | Method for preparing compositions |
Country Status (38)
Country | Link |
---|---|
US (3) | US6534087B2 (hu) |
EP (1) | EP1296656B1 (hu) |
JP (2) | JP4149803B2 (hu) |
KR (1) | KR100557845B1 (hu) |
CN (1) | CN1236764C (hu) |
AR (1) | AR029278A1 (hu) |
AT (1) | ATE334662T1 (hu) |
AU (2) | AU8184601A (hu) |
BR (1) | BRPI0112014B1 (hu) |
CA (1) | CA2411153C (hu) |
CY (1) | CY1105714T1 (hu) |
CZ (1) | CZ301813B6 (hu) |
DE (1) | DE60121953T2 (hu) |
DK (1) | DK1296656T3 (hu) |
EC (1) | ECSP024401A (hu) |
EG (1) | EG24141A (hu) |
ES (1) | ES2269441T3 (hu) |
HK (1) | HK1058314A1 (hu) |
HR (1) | HRP20021009B1 (hu) |
HU (1) | HU229550B1 (hu) |
IL (2) | IL153282A0 (hu) |
JO (1) | JO2247B1 (hu) |
MA (1) | MA26922A1 (hu) |
ME (1) | ME00672B (hu) |
MX (1) | MXPA02012583A (hu) |
MY (1) | MY129798A (hu) |
NO (1) | NO332181B1 (hu) |
NZ (1) | NZ523024A (hu) |
PE (1) | PE20020101A1 (hu) |
PL (1) | PL203804B1 (hu) |
PT (1) | PT1296656E (hu) |
RU (1) | RU2244542C2 (hu) |
SI (1) | SI1296656T1 (hu) |
TW (1) | TWI278325B (hu) |
UY (1) | UY26799A1 (hu) |
WO (1) | WO2002000201A2 (hu) |
YU (1) | YU96602A (hu) |
ZA (1) | ZA200209649B (hu) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9827423D0 (en) * | 1998-12-11 | 1999-02-03 | Relax Limited | Method of drying a solution |
AU8184601A (en) * | 2000-06-27 | 2002-01-08 | Hoffmann La Roche | Method for preparing a composition |
US20030027786A1 (en) | 2001-06-06 | 2003-02-06 | Karsten Maeder | Lipase inhibiting composition |
MY135783A (en) * | 2001-09-07 | 2008-06-30 | Meiji Dairies Corp | Nutritional composition for controlling blood sugar level |
JP4234017B2 (ja) | 2002-04-26 | 2009-03-04 | エフ.ホフマン−ラ ロシュ アーゲー | リパーゼ阻害薬及びグルコマンナンを含む医薬組成物 |
KR100517072B1 (ko) * | 2002-11-25 | 2005-09-26 | 주식회사 태평양 | 폴리올/고분자 마이크로캡슐 및 이를 이용한 효소 안정화방법 |
US9174176B2 (en) | 2003-01-09 | 2015-11-03 | Disperse Systems, Inc. | Ultrasonic dispersion apparatus, system, and method |
US20050089502A1 (en) * | 2003-08-21 | 2005-04-28 | Todd Schansberg | Effervescent delivery system |
US8940321B2 (en) | 2003-12-12 | 2015-01-27 | Otic Pharma Ltd. | Compositions for treatment of ear disorders and methods of use thereof |
US8030362B2 (en) * | 2003-12-12 | 2011-10-04 | Otic Pharma Ltd. | Compositions for treatment of ear disorders and methods of use thereof |
US20080269223A1 (en) * | 2004-04-06 | 2008-10-30 | Saibal Chakravorty | Mouth Dissolvable and Meltable, and Water Dispersable Delivery Formulation |
EP1790966A1 (en) * | 2004-09-15 | 2007-05-30 | Banyu Pharmaceutical Co., Ltd. | SAMPLING METHOD AND SAMPLING DEVICE, AND logD MEASURING METHOD AND logD MEASURING SYSTEM |
EP2163196A3 (en) * | 2004-12-31 | 2010-11-03 | Mikhail Yurievich Gotovsky | Device for measuring the presence of foreign substances in a living organism and for individually selecting preparations for increasing an organism's life activity |
US20060198856A1 (en) * | 2005-03-01 | 2006-09-07 | Keith Whitehead | Ibuprofen suspension stabilized with docusate sodium |
US20060246141A1 (en) * | 2005-04-12 | 2006-11-02 | Elan Pharma International, Limited | Nanoparticulate lipase inhibitor formulations |
US7984717B2 (en) * | 2005-04-29 | 2011-07-26 | Medtronic, Inc. | Devices for augmentation of lumen walls |
WO2006138431A2 (en) * | 2005-06-16 | 2006-12-28 | Eastman Chemical Company | Methods and pharmaceutical formulations for increasing bioavailability |
WO2006136197A1 (en) | 2005-06-21 | 2006-12-28 | V. Mane Fils | Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule |
US20070048364A1 (en) * | 2005-08-04 | 2007-03-01 | Yingxu Peng | Free flowing granules containing carbomer |
KR100669497B1 (ko) * | 2005-08-17 | 2007-01-16 | 보람제약주식회사 | 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법 |
AR056499A1 (es) * | 2005-09-06 | 2007-10-10 | Serapis Farmaceuticals Ltd | Compuestos |
US10010494B2 (en) | 2005-10-19 | 2018-07-03 | Menni Menashe Zinger | Methods for the treatment of hyperhidrosis |
EP1973406B1 (en) | 2005-12-28 | 2014-03-12 | Advanced Bionutrition Corporation | A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form |
US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
FR2895908B1 (fr) * | 2006-01-12 | 2008-03-28 | France Etat | Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir |
WO2007097325A1 (ja) | 2006-02-20 | 2007-08-30 | Chugai Seiyaku Kabushiki Kaisha | リン酸オセルタミビル含有医薬組成物 |
WO2007109127A2 (en) | 2006-03-16 | 2007-09-27 | Duke University | Methods, systems, and computer program products for performng real-time quadrature projection based fourier domain optical coherence tomography |
CN1820744B (zh) * | 2006-04-04 | 2011-01-26 | 中国人民解放军军事医学科学院毒物药物研究所 | 磷酸奥司他韦颗粒剂及其制备方法 |
EP1872777A1 (en) * | 2006-06-27 | 2008-01-02 | LEK Pharmaceuticals D.D. | Pharmaceutical composition comprising tetrahydrolipstatin |
KR100812824B1 (ko) | 2006-09-27 | 2008-03-12 | 주식회사 제닉 | 키토산과 폴리에틸렌글리콜을 이용한 생체친화성 저독성필름 |
CA2673120C (en) | 2006-12-18 | 2012-08-07 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
NZ582049A (en) * | 2007-05-18 | 2012-12-21 | Tti Ellebeau Inc | Transdermal delivery devices assuring an improved release of an active principle through a biological interface |
KR101439470B1 (ko) * | 2007-05-22 | 2014-09-16 | 한미사이언스 주식회사 | 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물 |
US20100317642A1 (en) * | 2007-10-15 | 2010-12-16 | Inventis Dds Pvt Limited | Pharmaceutical composition of orlistat |
PL216542B1 (pl) | 2008-03-20 | 2014-04-30 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku |
GB0900551D0 (en) | 2009-01-14 | 2009-02-11 | Horton Richard | Ingestible compositions and processes of preparation |
WO2010111565A2 (en) | 2009-03-27 | 2010-09-30 | Advanced Bionutrition Corporation | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
PL2435554T3 (pl) | 2009-05-26 | 2018-01-31 | Advanced Bionutrition Corp | Stabilna kompozycja suchego proszku zawierająca biologicznie aktywne mikroorganizmy i/lub materiały bioaktywne i sposoby jej wykonania |
WO2011040956A1 (en) * | 2009-09-29 | 2011-04-07 | Michael Burnet | Novel pesticide formulations |
KR100940745B1 (ko) * | 2009-10-15 | 2010-02-04 | 광동제약 주식회사 | 오를리스타트 및 아타풀지트 함유 복합제의 코팅펠렛 및 이를 이용한 제제 |
US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
SG182317A1 (en) | 2010-01-28 | 2012-08-30 | Advanced Bionutrition Corp | Dry glassy composition comprising a bioactive material |
KR101021030B1 (ko) * | 2010-03-25 | 2011-03-09 | 엘지이노텍 주식회사 | 형광체 코팅방법, 발광장치 제조방법 및 코팅된 형광체 |
AU2011236907B2 (en) * | 2010-04-07 | 2015-04-02 | Mitsubishi Gas Chemical Company, Inc. | S-adenosyl-L-methionine-containing dry yeast composition with excellent storage stability and process for producing same |
PL2603100T3 (pl) | 2010-08-13 | 2019-06-28 | Advanced Bionutrition Corp. | Kompozycja stabilizująca przechowywanie na sucho materiałów biologicznych |
AU2011320159B2 (en) | 2010-10-29 | 2016-12-22 | Western University Of Health Sciences | Ternary mixture formulations |
AU2012229476B2 (en) | 2011-03-01 | 2016-02-25 | The Procter & Gamble Company | Porous disintegratable solid substrate for personal health care applications |
EP2827905A4 (en) | 2012-03-23 | 2015-05-06 | Advanced Bionutrition Corp | STABILIZATION COMPOSITION FOR BIOLOGICAL SUBSTANCES |
CN103222964B (zh) * | 2013-01-29 | 2014-10-08 | 青岛大学 | 一种奥利司他口服制剂及其制备方法 |
GB2524496A (en) * | 2014-03-24 | 2015-09-30 | British Airways Plc | Dynamic tracking and control of passenger travel progress |
US9938558B2 (en) | 2015-06-25 | 2018-04-10 | Ascus Biosciences, Inc. | Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
DK3314007T3 (da) | 2015-06-25 | 2024-04-22 | Native Microbials Inc | Fremgangsmåder, apparater og systemer til analyse af mikroorganismestammer fra komplekse heterogene miljøer til forudsigelse og identificering af funktionelle forbindelser og interaktioner derimellem og udvælgelse og syntese af mikrobielle ensembler baseret derpå |
US10851399B2 (en) | 2015-06-25 | 2020-12-01 | Native Microbials, Inc. | Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
CA2994112C (en) | 2015-07-29 | 2023-08-08 | Advanced Bionutrition Corp. | Stable dry probiotic compositions for special dietary uses |
JP6778051B2 (ja) * | 2016-08-18 | 2020-10-28 | 沢井製薬株式会社 | オセルタミビルリン酸塩含有医薬組成物 |
EP3562954A1 (en) | 2016-12-28 | 2019-11-06 | Ascus Biosciences, Inc. | Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon |
WO2019069108A1 (en) * | 2017-10-04 | 2019-04-11 | Debreceni Egyetem | SOLID GALENIC FORM, MOLDED, GASTRIC RETENTION AND EXTENDED RELEASE AND METHOD OF PREPARING THE SAME |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS608117B2 (ja) * | 1977-02-08 | 1985-02-28 | 財団法人微生物化学研究会 | 新生理活性物質エステラスチンおよびその製造法 |
US4489438A (en) * | 1982-02-01 | 1984-12-18 | National Data Corporation | Audio response system |
CA1247547A (en) | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
DE69331839T2 (de) | 1992-01-29 | 2002-12-12 | Takeda Chemical Industries Ltd | Schnellösliche Tablette und ihre Herstellung |
US5560921A (en) | 1992-06-01 | 1996-10-01 | The Procter & Gamble Company | Chewable decongestant compositions |
US5343672A (en) | 1992-12-01 | 1994-09-06 | Scherer Ltd R P | Method for manufacturing freeze dried dosages in a multilaminate blister pack |
NZ262562A (en) * | 1993-02-23 | 1996-04-26 | Warner Lambert Co | Preparation of solvent free pharmaceutical compositions |
DE4317320A1 (de) | 1993-05-25 | 1994-12-01 | Boehringer Mannheim Gmbh | Neue Thiazolidindione und diese enthaltende Arzneimittel |
US5455046A (en) * | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US5536264A (en) * | 1993-10-22 | 1996-07-16 | The Procter & Gamble Company | Absorbent composites comprising a porous macrostructure of absorbent gelling particles and a substrate |
US5523106A (en) * | 1994-02-03 | 1996-06-04 | Nabisco, Inc. | Juice-based expanded snacks and process for preparing them |
CN102952033A (zh) | 1995-02-27 | 2013-03-06 | 吉里德科学公司 | 新颖化合物,其合成方法及治疗用途 |
DE759917T1 (de) | 1995-02-27 | 1998-10-22 | Gilead Sciences Inc | Neue selektive inhibitoren viraler oder bakterieller neuraminidasen |
DE69628007T2 (de) * | 1995-06-07 | 2003-11-27 | Elan Drug Delivery Ltd | Verfahren zur stabilen einarbeitung von substanzen in trockene geschäumte glasmatrizen und auf diese weise hergestellte zusammensetzungen |
US5763483A (en) | 1995-12-29 | 1998-06-09 | Gilead Sciences, Inc. | Carbocyclic compounds |
EP0893992B1 (en) * | 1996-04-16 | 2004-03-03 | Novartis Consumer Health S.A. | Fast disintegrating oral dosage form |
US5766520A (en) * | 1996-07-15 | 1998-06-16 | Universal Preservation Technologies, Inc. | Preservation by foam formation |
CN1233169A (zh) * | 1996-10-14 | 1999-10-27 | 弗·哈夫曼-拉罗切有限公司 | 一种粉末状制剂的制备工艺 |
US6004996A (en) | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
JPH11137208A (ja) | 1997-11-14 | 1999-05-25 | Nikken Chem Co Ltd | 口腔内速溶性固形物及びその製造方法 |
US6267952B1 (en) | 1998-01-09 | 2001-07-31 | Geltex Pharmaceuticals, Inc. | Lipase inhibiting polymers |
ES2272066T3 (es) * | 1998-04-09 | 2007-04-16 | F. Hoffmann-La Roche Ag | Proceso para la manufactura de particulas con tamaño de (sub)micras por disolucion de gas comprimido y surfactantes. |
CN1152680C (zh) * | 1998-08-14 | 2004-06-09 | 霍夫曼-拉罗奇有限公司 | 含有脂酶抑制剂和壳聚糖的药物组合物 |
ATE293970T1 (de) | 1998-08-14 | 2005-05-15 | Hoffmann La Roche | Lipasehemmer enthaltende pharmazeutische zusammensetzungen |
GB9827423D0 (en) * | 1998-12-11 | 1999-02-03 | Relax Limited | Method of drying a solution |
US6342249B1 (en) * | 1998-12-23 | 2002-01-29 | Alza Corporation | Controlled release liquid active agent formulation dosage forms |
GB9900416D0 (en) | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
ATE400252T1 (de) | 1999-02-10 | 2008-07-15 | Pfizer Prod Inc | Pharmazeutische feste dispersionen |
GB9904629D0 (en) * | 1999-03-02 | 1999-04-21 | Danbiosyst Uk | Oral drug delivery system |
FR2791569B1 (fr) * | 1999-03-31 | 2003-05-09 | Pf Medicament | Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention |
AU8184601A (en) * | 2000-06-27 | 2002-01-08 | Hoffmann La Roche | Method for preparing a composition |
-
2001
- 2001-06-18 AU AU8184601A patent/AU8184601A/xx active Pending
- 2001-06-18 AT AT01960323T patent/ATE334662T1/de active
- 2001-06-18 BR BRPI0112014A patent/BRPI0112014B1/pt not_active IP Right Cessation
- 2001-06-18 CA CA002411153A patent/CA2411153C/en not_active Expired - Lifetime
- 2001-06-18 WO PCT/EP2001/006834 patent/WO2002000201A2/en active IP Right Grant
- 2001-06-18 CZ CZ20030212A patent/CZ301813B6/cs not_active IP Right Cessation
- 2001-06-18 NZ NZ523024A patent/NZ523024A/en not_active IP Right Cessation
- 2001-06-18 PT PT01960323T patent/PT1296656E/pt unknown
- 2001-06-18 DK DK01960323T patent/DK1296656T3/da active
- 2001-06-18 YU YU96602A patent/YU96602A/sh unknown
- 2001-06-18 SI SI200130626T patent/SI1296656T1/sl unknown
- 2001-06-18 HU HU0302060A patent/HU229550B1/hu unknown
- 2001-06-18 AU AU2001281846A patent/AU2001281846B2/en not_active Expired
- 2001-06-18 PL PL365803A patent/PL203804B1/pl unknown
- 2001-06-18 JP JP2002504983A patent/JP4149803B2/ja not_active Expired - Lifetime
- 2001-06-18 ES ES01960323T patent/ES2269441T3/es not_active Expired - Lifetime
- 2001-06-18 IL IL15328201A patent/IL153282A0/xx active IP Right Grant
- 2001-06-18 RU RU2003100506/15A patent/RU2244542C2/ru active
- 2001-06-18 EP EP01960323A patent/EP1296656B1/en not_active Expired - Lifetime
- 2001-06-18 KR KR1020027017564A patent/KR100557845B1/ko active IP Right Grant
- 2001-06-18 CN CNB018119026A patent/CN1236764C/zh not_active Expired - Lifetime
- 2001-06-18 ME MEP-2008-906A patent/ME00672B/me unknown
- 2001-06-18 DE DE60121953T patent/DE60121953T2/de not_active Expired - Lifetime
- 2001-06-18 MX MXPA02012583A patent/MXPA02012583A/es active IP Right Grant
- 2001-06-21 PE PE2001000603A patent/PE20020101A1/es active IP Right Grant
- 2001-06-22 TW TW090115313A patent/TWI278325B/zh not_active IP Right Cessation
- 2001-06-24 JO JO200199A patent/JO2247B1/en active
- 2001-06-24 EG EG20010680A patent/EG24141A/xx active
- 2001-06-25 MY MYPI20012988A patent/MY129798A/en unknown
- 2001-06-25 AR ARP010103011A patent/AR029278A1/es not_active Application Discontinuation
- 2001-06-25 US US09/891,069 patent/US6534087B2/en not_active Expired - Lifetime
- 2001-06-26 UY UY26799A patent/UY26799A1/es not_active IP Right Cessation
-
2002
- 2002-10-08 US US10/266,363 patent/US7074431B2/en not_active Expired - Lifetime
- 2002-11-27 ZA ZA200209649A patent/ZA200209649B/en unknown
- 2002-12-04 IL IL153282A patent/IL153282A/en unknown
- 2002-12-17 HR HR20021009A patent/HRP20021009B1/xx not_active IP Right Cessation
- 2002-12-23 NO NO20026197A patent/NO332181B1/no not_active IP Right Cessation
- 2002-12-23 EC EC2002004401A patent/ECSP024401A/es unknown
- 2002-12-26 MA MA26978A patent/MA26922A1/fr unknown
-
2004
- 2004-02-19 HK HK04101186A patent/HK1058314A1/xx not_active IP Right Cessation
-
2006
- 2006-02-15 US US11/354,716 patent/US20060134205A1/en not_active Abandoned
- 2006-10-19 CY CY20061101498T patent/CY1105714T1/el unknown
-
2007
- 2007-07-10 JP JP2007180722A patent/JP2007302683A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0302060A2 (hu) | Eljárás készítmények elżállítására | |
FI20011852A (fi) | Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi | |
CY1112510T1 (el) | Φαρμακευτικο παρασκευασμα υπο τη μορφη παστας το οποιο περιεχει ενα ασταθες στα οξεα δραστικο συστατικο | |
DE60139087D1 (de) | Verfahren zu Herstellung von Zubereitungen enthaltend einen Steroidhormon und ein Stabilisierungsmittel in nicht-kristallinen Form | |
HUP0401344A2 (hu) | Gyógyszerkészítmények opioidokkal való visszaélés megakadályozására, és eljárás előállításukra | |
HUP0100562A2 (hu) | Szferoidok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
NO20071354L (no) | anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme. | |
HUP0002490A2 (hu) | Csersav-polimer kompozíciók gyógyászati anyagok szabályozott leadására, különösen a szájüregben | |
RU2006147244A (ru) | Способ составления быстро диспергируемых лекарственных форм, содержащих по меньшей мере один рыбий желатин, который выбирают на основе молекулярной массы | |
HUP0300334A2 (hu) | Gyógyászati készítmények és eljárások azok elżállítására | |
ATE326240T2 (de) | Zusammensetzung zur prävention kardiovaskulärer erkrankungen | |
HUP0105481A2 (hu) | Klaritromicint vagy származékait tartalmazó gyógyászati készítmények és eljárás előállításukra, valamint alkalmazásuk | |
HUP0004363A2 (hu) | Miltefosint tartalmazó orális szilárd gyógyszerkészítmények leishmaniasis kezelésére | |
MXPA04005783A (es) | Formulacion farmaceutica que comprende ciclosporina y uso de la misma. | |
BR0115989A (pt) | Preparação farmacêutica na forma de uma suspensão compreendendo um ingrediente ativo instável a ácido | |
HUP0001583A2 (hu) | Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké | |
RS99503A (en) | Pyrrolidine oxadiazole- and thiadiazole derivatives | |
DE60104442D1 (de) | Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen | |
EP0815851A3 (en) | Method of reducing irritativeness of surface active agents and aqueous compositions with reduced irritativeness | |
MD2069C2 (ro) | Preparat antiseptic şi procedeu de preparare a lui | |
CA2066945A1 (en) | Oral, cutaneous and intravaginal pharmaceutical compositions in the form of foam |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB9A | Succession in title |
Owner name: CHEPLAPHARM ARZNEIMITTEL GMBH, DE Free format text: FORMER OWNER(S): F.HOFFMANN-LA ROCHE AG., CH |